Swiss National Bank raised its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 3.1% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,443,332 shares of the medical research company’s stock after buying an additional 43,600 shares during the quarter. Swiss National Bank owned about 0.37% of Thermo Fisher Scientific worth $251,818,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Proficio Capital Partners LLC lifted its stake in Thermo Fisher Scientific by 71.5% in the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after buying an additional 253 shares in the last quarter. Cribstone Capital Management LLC lifted its stake in Thermo Fisher Scientific by 8.7% in the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after buying an additional 50 shares in the last quarter. Shine Investment Advisory Services Inc. bought a new position in Thermo Fisher Scientific in the second quarter valued at approximately $113,000. Chicago Partners Investment Group LLC bought a new position in Thermo Fisher Scientific in the second quarter valued at approximately $108,000. Finally, CWM LLC lifted its stake in Thermo Fisher Scientific by 17.0% in the second quarter. CWM LLC now owns 710 shares of the medical research company’s stock valued at $124,000 after buying an additional 103 shares in the last quarter. 83.36% of the stock is currently owned by hedge funds and other institutional investors.

In other Thermo Fisher Scientific news, Director Jim P. Manzi sold 11,318 shares of the firm’s stock in a transaction on Friday, August 18th. The stock was sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the transaction, the director now directly owns 38,757 shares in the company, valued at approximately $6,702,635.58. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jim P. Manzi sold 1,000 shares of the firm’s stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $175.20, for a total value of $175,200.00. Following the transaction, the director now owns 38,757 shares in the company, valued at $6,790,226.40. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 52,738 shares of company stock worth $9,302,112. Company insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Inc (TMO) opened at 193.21 on Friday. The company’s 50-day moving average is $186.68 and its 200-day moving average is $173.88. The firm has a market capitalization of $75.37 billion, a P/E ratio of 33.66 and a beta of 1.05. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The business had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.92 billion. During the same period last year, the business earned $2.03 EPS. The business’s revenue was up 10.2% on a year-over-year basis. Equities analysts forecast that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.31%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.45%.

A number of research analysts have weighed in on TMO shares. Deutsche Bank AG set a $200.00 price target on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Saturday, June 10th. BidaskClub lowered shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 27th. Citigroup Inc. reaffirmed a “buy” rating and issued a $201.00 price target (up previously from $182.00) on shares of Thermo Fisher Scientific in a research note on Monday, July 10th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $199.00 price target on the stock in a research note on Tuesday, July 11th. Finally, Wells Fargo & Company reaffirmed an “outperform” rating and issued a $200.00 price target (up previously from $195.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 13th. One analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $202.21.

ILLEGAL ACTIVITY NOTICE: “Swiss National Bank Increases Holdings in Thermo Fisher Scientific Inc (TMO)” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/10/08/swiss-national-bank-increases-holdings-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.